Latest Breaking News On - Artificial axon - Page 1 : comparemela.com

Krystyn Van Vliet, PhD, of Cornell University, discusses the scalability of 3D platforms in multiple sclerosis (MS) drug discovery and compares their costs with those of other drug discovery methods.

Anna jagielskaDaniela espinosa hoyosKrystyn van vlietCornell university meinig school of biomedical engineeringAmericas committee for treatmentCornell universityMeinig schoolBiomedical engineeringAmericas committeeOvercome barriersDrug discoveryArtificial axonArtificial axon labs